美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Methyltestosterone	Capsule			Develop a dissolution method			2024/01/03
Methyltestosterone	Tablet			Develop a dissolution method			2023/09/15
Metoclopramide HCl	Tablet (Orally Disintegrating)			Develop a dissolution method			2023/09/15
Metoclopramide HCl	Tablet			Develop a dissolution method			2024/01/03
Metolazone	Tablet			Refer to USP			2020/04/02
Metoprolol Succinate	Capsule, extended release	II (Paddle)	50	Phosphate buffer, pH 6.8	500	1, 4, 8, 12, 16, 20 and 24 hours	2025/09/08
Metoprolol Succinate	Tablet (Extended Release)			Refer to USP			2007/07/25
Metoprolol Tartrate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Metronidazole	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Metronidazole	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Metyrosine	Capsule			Refer to USP			2018/02/15
Mexiletine HCl	Capsule			Refer to FDA's Dissolution Guidance, 2018			2021/04/22
Miconazole	Tablet (Buccal)	I (Basket)	60	0.5% SDS (Sodium dodecylsulfate) in water-pH adjusted to 6.5 ± 0.5	1000	1, 2, 4, 6, 8, 10 and 12 hours	2010/10/28
Miconazole Nitrate	Suppository (Vaginal)	I (Basket)	100	0.45% SLS in water	900	15, 30, 45 and 60	2009/10/08
Midodrine HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Midostaurin	Capsule			Develop a dissolution method			2023/09/15
Mifepristone	Tablet	II (Paddle)	75	0.01 N HCl	900	5, 10, 15, 20 and 30	2008/01/14
Mifepristone [300 mg]	Tablet	II (Paddle)	50	pH 1.8 KCl Buffer	900	10, 15, 20, 30 and 45	2016/03/17
Migalastat Hydrochloride	Capsule			Refer to FDA's Dissolution Guidance, 2018			2025/06/23
Miglitol	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02